Development of AAV2-hAADC gene therapy for Parkinson's disease designed to enhance dopamine metabolism

Authors
Category Primary study
JournalJapanese Journal of Neurosurgery
Year 2008
This article has no abstract
Epistemonikos ID: 6c80deca8ff3b5e7a253078ff7cac5f465d1e96c
First added on: Feb 04, 2025